Metabolic syndrome in relation to risk of meningioma-Reference-Cited by-同舟云学术

Metabolic syndrome in relation to risk of meningioma

Published:2016-11-26 Issue:2 Volume:8 Page:2284-2292
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Seliger Corinna¹,Meier Christoph R.²³⁴,Becker Claudia²,Jick Susan S.³,Proescholdt Martin⁵,Bogdahn Ulrich¹,Hau Peter¹,Leitzmann Michael F.⁶

Affiliation:

1. Department of Neurology and Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, Regensburg, Germany

2. Basel Pharmacoepidemiology Unit, Division of CIinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland

3. Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Boston University, MA, USA

4. Hospital Pharmacy, University Hospital Basel, Basel, Switzerland

5. Department of Neurosurgery, Regensburg University Hospital, Regensburg, Germany

6. Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lifestyle and metabolic factors affect risk for meningioma in women: a prospective population-based study (The Cohort of Norway);Frontiers in Oncology;2024-08-12

2. Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis;IgMin Research;2024-05-15

3. Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series;Journal of Neuro-Oncology;2024-04-17

4. The Natural History and Treatment of Meningiomas: An Update;Seminars in Neurology;2023-12-05

5. The causal relationship between genetically determined telomere length and meningiomas risk;Frontiers in Neurology;2023-08-24